http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2345413-A4
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89d98da599a7fb715284473aee477c77 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
| filingDate | 2009-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d50925960438a34edcc9f48b323b018b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_980896cdaba3998fcc9a12b16f0819e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cecf8656cd1a0d840456ba2cd384ea6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea742c3238b6f4fcdd0314872b39a6b2 |
| publicationDate | 2013-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2345413-A4 |
| titleOfInvention | COMPOSITION AND USE OF LONG-DERMAL BIOADHESIVE ENDOPARASITICIDE ORAL GEL BASED ON DORAMECTIN |
| abstract | The present invention relates to the composition of an oral bioadhesive endoparasiticide gel based on doramectin, having a high degree of adhesion to equine oral mucosa and having a sweet flavour greatly facilitating the dosing thereof, procedures for the preparation and the utilisation thereof. Gastrointestinal helminthosis is a parasitic condition caused by nematodes of diverse families occassioning serious gastrointestinal disorders in equine livestock. Control of this illness is of great importance and advantageously achievable through the employment of appropiate antihelmintic agents such as doramectin, being is a chemical compound widely administered by parenteral 1 route and infrequently by oral route in liquid form due to the organoleptic and physicochemical characteristics of the compositions known up to the present. The present invention demonstrates that it is possible to administer doramectin in the pharmaceutical form of an oral gel at concentrations of up to 5.0% weight/volume, overcoming the organoleptic and physicochemical restrictions of the compositions known up to the present. |
| priorityDate | 2008-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.